🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the abuse potential and safety of ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-08
Trial ID
NCT02218021
Treatments Being Tested
This clinical lactation study is to provide information regarding the PK an...
Status
Completed
Location
Alkermes Investigator Site
Start Date
2022-09-14
Trial ID
NCT05547100
Treatments Being Tested
This is a Phase 3 study designed to evaluate the safety and tolerability of...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-02
Trial ID
NCT02085135
Treatments Being Tested
This is a Phase 2, randomized, placebo-controlled multicenter study, which ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2013-06
Trial ID
NCT01903837
Treatments Being Tested
This double-blind, randomized study will evaluate the efficacy, safety and ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-05
Trial ID
NCT02161718
Treatments Being Tested
This study will evaluate the impact of CYP3A4 induction on the single-dose ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2015-07
Trial ID
NCT02545439
Treatments Being Tested
This study will evaluate the impact of water consumption on the pharmacokin...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2015-07
Trial ID
NCT02521857
Treatments Being Tested
To compare changes in body mass index (BMI) Z-score following treatment wit...
Status
Recruiting
Location
Alkermes Investigator Site
Start Date
2022-06-30
Trial ID
NCT05303064
Treatments Being Tested
To provide continued access to OLZ/SAM for pediatric participants with schi...
Status
Available
Location
Alkermes Investigator Site
Start Date
TBD
Trial ID
NCT07744113
Treatments Being Tested
To evaluate the safety, tolerability, and pharmacokinetics of olanzapine an...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2021-07-22
Trial ID
NCT04987658
Treatments Being Tested